The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma

Published:2011-01-14 Issue:4 Volume:25 Page:681-688
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ruminy P,Etancelin P,Couronné L,Parmentier F,Rainville V,Mareschal S,Bohers E,Burgot C,Cornic M,Bertrand P,Lenormand B,Picquenot J-M,Jardin F,Tilly H,Bastard C

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2010302.pdf

Reference29 articles.

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511.

2. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282.

3. de Jong D, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Lee A et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications—a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007; 25: 805–812.

4. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM . A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9991–9996.

5. Jais JP, Haioun C, Molina TJ, Rickman DS, de RA, Berger F et al. The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab. Leukemia 2008; 22: 1917–1924.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study);Blood;2024-08-01

2. Complete detection of FR1 to FR3 primer‐based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED‐2 protocol is associated with poor prognosis in patients with diffuse large B‐cell lymphoma;eJHaem;2024-06-18

3. Mutations in the IgG B cell receptor associated with class-switched B cell lymphomas;2024-04-13

4. Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface;Oncotarget;2024-04-12

5. Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL;Journal of Experimental Medicine;2024-03-21